BIO-key(R) International, Inc. Partners Highlight Fingerprint Biometric Technology Solutions for Healthcare at HIMSS

Mon Mar 4, 2013 8:00am EST

* Reuters is not responsible for the content in this press release.

  WALL, NJ, Mar 04 (Marketwire) -- 
BIO-key International, Inc. (OTCQB: BKYI), a global leader in fingerprint
biometric identification solutions, advanced mobile credentialing and
identity verification technologies, today reported that the company will
be attending the Health Information and Management Systems Society
(HIMSS) annual meeting in New Orleans, Louisiana, March 3rd - 7th
supporting our partners as they present BIO-key technology to attendees
at the HIMSS conference.

    BIO-key will have a strong presence at HIMSS 2013, as healthcare partners
such as Allscripts, Epic, IBM, CA Technologies, Caradigm, Indigo
Identyware and Healthcast attending the event offer BIO-key solutions. 

    Company partners will be offering demonstrations of integrated solutions
for secure, compliant two-factor authentication. BIO-key customer
McKesson will also be in attendance at HIMSS. Our fingerprint biometric
technology is embedded within their AcuDoseRx(R) automated medication
dispensing cabinets.

    BIO-key's fingerprint biometric technology offers strong authentication
in addition to optimum convenience enabling healthcare providers to
greatly reduce or eliminate the use of passwords, cards and tokens and
increase the amount of time caring for patients. The company's software
achieved top scores for speed and accuracy in the most recent National
Institute for Standards of Technology (NIST) biometric evaluation. NIST
sets the standards for the DEA ePrescription compliance guidelines.

    "The HIMSS conference allows BIO-key and our healthcare partners to
co-present innovative solutions for EHR systems to the CEO's and CIO's
from leading hospitals and clinics," stated Mike DePasquale, CEO,
BIO-key. "The provider's frustration with passwords along with the
organizations requirement to meet strict ePrescription compliance
guidelines is motivating healthcare executives to educate themselves
about the benefits of integrating BIO-key technology."

    About BIO-key
 BIO-key International, Inc., headquartered in Wall, New
Jersey, develops and delivers advanced identification solutions to
commercial and government enterprises, integrators, and custom
application developers. BIO-key's award winning, high performance,
scalable, cost-effective and easy-to-deploy biometric finger
identification technology accurately identifies and authenticates users
of wireless and enterprise applications. Our solutions are used in local
embedded OEM products as well as some of the world's largest
identification deployments to improve security, guarantee identity, and
help reduce identity theft. BIO-key's technology is offered directly or
by market leading partners around the world. (http://www.bio-key.com)

    BIO-key Safe Harbor Statement
 Certain statements contained in this press
release may be construed as "forward-looking statements" as defined in
the Private Securities Litigation Reform Act of 1995 (the "Act"). The
words "estimate," "project," "intends," "expects," "anticipates,"
"believes" and similar expressions are intended to identify
forward-looking statements. Such forward-looking statements are made
based on management's beliefs, as well as assumptions made by, and
information currently available to, management pursuant to the
"safe-harbor" provisions of the Act. These statements are subject to
certain risks and uncertainties that may cause actual results to differ
materially from those projected on the basis of these statements. These
risks and uncertainties include, without limitation, our history of
losses and limited revenue, our ability to develop new products and
evolve existing ones, the impact on our business of the recent financial
crisis in the global capital markets and negative global economic trends,
our ability to attract and retain key personnel. For a more complete
description of these and other risk factors that may affect the future
performance of BIO-key International, Inc., see "Risk Factors" in the
Company's Annual Report on Form 10-K for the year ended December 31, 2011
and its other filings with the Securities and Exchange Commission.
Readers are cautioned not to place undue reliance on these
forward-looking statements, which speak only as of the date made. The
Company also undertakes no obligation to disclose any revision to these
forward-looking statements to reflect events or circumstances after the
date made or to reflect the occurrence of unanticipated events. 

    

Contacts: 
BIO-key International, Inc.
Scott Mahnken
732-359-1113 

Copyright 2013, Marketwire, All rights reserved.

-0-
Comments (0)
This discussion is now closed. We welcome comments on our articles for a limited period after their publication.